In today’s recent session, 0.75 million shares of the BioCardia Inc. (NASDAQ:BCDA) have been traded, and its beta is 1.26. Most recently the company’s share price was $2.87, and it changed around $0.08 or 2.80% from the last close, which brings the market valuation of the company to $10.04M. BCDA at last check was trading at a discount to its 52-week high of $23.25, offering almost -710.1% off that amount. The share price’s 52-week low was $1.96, which indicates that the recent value has risen by an impressive 31.71% since then. We note from BioCardia Inc.’s average daily trading volume that its 10-day average is 0.23 million shares, with the 3-month average coming to 817.49K.
BioCardia Inc. stock received a consensus recommendation rating of Buy, based on a mean score of 1.00. If we narrow it down even further, the data shows that 0 out of 1 analysts rate the stock as a Sell; another 0 rate it as Overweight. Among the rest, 0 recommended BCDA as a Hold, whereas 1 deemed it a Buy, and 0 rated it as Underweight. BioCardia Inc. is expected to report earnings per share of 0 for the current quarter.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
BioCardia Inc. (NASDAQ:BCDA) trade information
Instantly BCDA has been showing a green trend so far today with a performance of 2.80% on intraday trading today. The performance over the last five days has remained in the green territory. The rise to weekly highs of 3.26 on recent trading dayincreased the stock’s daily price by 11.96%. The company’s shares are currently down -71.21% year-to-date, but still up 5.44% over the last five days. On the other hand, BioCardia Inc. (NASDAQ:BCDA) is -28.30% down in the 30-day period. We can see from the shorts that 1.83 million shares have been sold at a short interest cover period of 0.95 day(s).
BioCardia Inc. (BCDA) estimates and forecasts
BioCardia Inc. share prices are performing particularly well compared to other companies within the same industry. As is evident from the statistics, the company’s shares have fallen -49.97 percent over the past six months and at a 38.67% annual growth rate that is well above the industry average of 17.20%. The year-over-year growth rate is expected to be 4.80%, up from the previous year.
1 analysts expect BioCardia Inc. to make 3k in revenue for the current ending quarter. The company’s sales for the same quarters a year ago were 64k and 43k respectively. Forecasts for the next quarter put sales growth at -93.00%.
Looking at the company’s year-over-year earnings, the past five years showed a positive earnings growth rate of 30.13%.
BCDA Dividends
BioCardia Inc.’s next quarterly earnings report is expected to be released on 2024-Mar-27.
BioCardia Inc. (NASDAQ:BCDA)’s Major holders
Upon looking at major shareholders, it appears that insiders hold 18.25% of BioCardia Inc. shares, and 2.47% of them are in the hands of institutional investors. The stock currently has a share float of 3.03%. BioCardia Inc. stock is held by 10.0 institutions, with ADVISOR GROUP HOLDINGS, INC. being the largest institutional investor. By 2024-06-30, it held 0.0445% of the shares, which is about 11189.0 shares worth $3798.0.
Vanguard Extended Market Index Fund and Fidelity Extended Market Index Fund were the top two Mutual Funds as of Jun 30, 2024. The former held 12.62 shares worth $36040.0, making up 0.59% of all outstanding shares. On the other hand, Fidelity Extended Market Index Fund held roughly 6.37 shares worth around $18194.0, which represents about 0.30% of the total shares outstanding.
